Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siguo Hao

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Oncology Letters|October 16, 2019
A-1210477, a selective MCL-1 inhibitor, overcomes ABT-737 resistance in AMLQing Wang, Siguo Hao
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2006
CD8+ cytotoxic T-APC stimulate central memory CD8+ T cell responses via acquired peptide-MHC class I complexes and CD80 costimulation, and IL-2 secretionDajing Xia, Siguo Hao, Jim Xiang
Journal of Leukocyte Biology|July 13, 2007
Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memorySiguo Hao, Jinying Yuan, Jim Xiang
Cancer Biotherapy & Radiopharmaceuticals|November 6, 2007
Review: cancer immunotherapy by exosome-based vaccinesSiguo Hao, Terence Moyana, Jim Xiang
BMC Neurology|January 25, 2025
Guillain-Barré syndrome in patients with multiple myeloma: three cases report and literature reviewZhichao Li, Fang Huang, Siguo Hao
Methods in Molecular Medicine|June 22, 2005
Genetically engineered myeloma cell vaccineSiguo Hao, Tim Chan, Jim Xiang
Journal of Leukocyte Biology|September 19, 2006
CD4(+) T cells stimulate memory CD8(+) T cell expansion via acquired pMHC I complexes and costimulatory molecules, and IL-2 secretionMeiqing Shi, Siguo Hao, Tim Chan, et al.
Biochemical and Biophysical Research Communications|November 14, 2018
IL-10 gene-modified dendritic cells-induced type 1 T regulatory cells inhibit graft-versus-host disease while preserving graft-versus-leukemia effectJiangbo Wan, Fang Huang, Weiwei Hu, et al.
Leukemia & Lymphoma|January 11, 2019
MCL-1 or BCL-xL-dependent resistance to the BCL-2 antagonist (ABT-199) can be overcome by specific inhibitor as single agents and in combination with ABT-199 in acute myeloid leukemia cellsQing Wang, Jiangbo Wan, Wenhao Zhang, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|November 14, 2017
Enhancement of Anti-Leukemia Immunity by Leukemia-Derived Exosomes Via Downregulation of TGF-β1 ExpressionFang Huang, Jiangbo Wan, Weiwei Hu, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Oncology Letters|October 16, 2019
A-1210477, a selective MCL-1 inhibitor, overcomes ABT-737 resistance in AMLQing Wang, Siguo Hao
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2006
CD8+ cytotoxic T-APC stimulate central memory CD8+ T cell responses via acquired peptide-MHC class I complexes and CD80 costimulation, and IL-2 secretionDajing Xia, Siguo Hao, Jim Xiang
Journal of Leukocyte Biology|July 13, 2007
Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memorySiguo Hao, Jinying Yuan, Jim Xiang
Cancer Biotherapy & Radiopharmaceuticals|November 6, 2007
Review: cancer immunotherapy by exosome-based vaccinesSiguo Hao, Terence Moyana, Jim Xiang
BMC Neurology|January 25, 2025
Guillain-Barré syndrome in patients with multiple myeloma: three cases report and literature reviewZhichao Li, Fang Huang, Siguo Hao
Methods in Molecular Medicine|June 22, 2005
Genetically engineered myeloma cell vaccineSiguo Hao, Tim Chan, Jim Xiang
Journal of Leukocyte Biology|September 19, 2006
CD4(+) T cells stimulate memory CD8(+) T cell expansion via acquired pMHC I complexes and costimulatory molecules, and IL-2 secretionMeiqing Shi, Siguo Hao, Tim Chan, et al.
Biochemical and Biophysical Research Communications|November 14, 2018
IL-10 gene-modified dendritic cells-induced type 1 T regulatory cells inhibit graft-versus-host disease while preserving graft-versus-leukemia effectJiangbo Wan, Fang Huang, Weiwei Hu, et al.
Leukemia & Lymphoma|January 11, 2019
MCL-1 or BCL-xL-dependent resistance to the BCL-2 antagonist (ABT-199) can be overcome by specific inhibitor as single agents and in combination with ABT-199 in acute myeloid leukemia cellsQing Wang, Jiangbo Wan, Wenhao Zhang, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|November 14, 2017
Enhancement of Anti-Leukemia Immunity by Leukemia-Derived Exosomes Via Downregulation of TGF-β1 ExpressionFang Huang, Jiangbo Wan, Weiwei Hu, et al.
Pageof 7